Center-Authored Papers

Filters: Author is Monnat, Raymond J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Shiovitz S, Bertagnolli MM, Renfro LA, Nam E, Foster NR, Dzieciatkowski S, Luo Y, Lao VV, Monnat RJ, Emond MJ et al..  2014.  CpG Island Methylator Phenotype is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage 3 Colon Cancer.. Gastroenterology. Abstract
M
Metzger MJ, Stoddard BL, Monnat RJ.  2013.  PARP-mediated repair, homologous recombination, and back-up non-homologous end joining-like repair of single-strand nicks.. DNA repair. 12(7):529-34. Abstract
McConnell Smith A, Takeuchi R, Pellenz S, Davis L, Maizels N, Monnat RJ, Stoddard BL.  2009.  Generation of a nicking enzyme that stimulates site-specific gene conversion from the I-AniI LAGLIDADG homing endonuclease.. Proceedings of the National Academy of Sciences of the United States of America. 106(13):5099-104. Abstract
L
Li H, Ulge UY, Hovde BT, Doyle LA, Monnat RJ.  2012.  Comprehensive homing endonuclease target site specificity profiling reveals evolutionary constraints and enables genome engineering applications.. Nucleic acids research. 40(6):2587-98. Abstract
Li H, Pellenz S, Ulge U, Stoddard BL, Monnat RJ.  2009.  Generation of single-chain LAGLIDADG homing endonucleases from native homodimeric precursor proteins.. Nucleic acids research. 37(5):1650-62. Abstract
Lauper JM, Krause A, Vaughan TL, Monnat RJ.  2013.  Spectrum and risk of neoplasia in Werner syndrome: a systematic review.. PloS one. 8(4):e59709. Abstract
Lao VV, Welcsh P, Luo Y, Carter KT, Dzieciatkowski S, Dintzis S, Meza J, Sarvetnick NE, Monnat RJ, Loeb LA et al..  2013.  Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers.. Translational oncology. 6(4):458-69. Abstract
H
Hughes BT, Sidorova J, Swanger J, Monnat RJ, Clurman BE.  2013.  Essential role for Cdk2 inhibitory phosphorylation during replication stress revealed by a human Cdk2 knockin mutation.. Proceedings of the National Academy of Sciences of the United States of America. 110(22):8954-9. Abstract
B
Bosch LJW, Luo Y, Lao VV, Snaebjornsson P, Trooskens G, Vlassenbroeck I, Mongera S, Tang W, Welcsh P, Herman JG et al..  2016.  WRN promoter CpG island hypermethylation does not predict more favorable outcomes for metastatic colorectal cancer patients treated with irinotecan-based therapy.. Clinical cancer research : an official journal of the American Association for Cancer Research. 22(18):4612-4622. Abstract